B. Braun News

Latest News

• Tuesday, February 22, 2022

  AVA, B. Braun Launch Second Fundamentals of Peripheral Intravenous Vascular Access Course

  PIV 201 pre-licensure course focuses on hands-on insertion techniques, infection prevention, patient care

  Read More
• Friday, January 28, 2022

  B. Braun Receives FDA Approval of Daytona Beach Pharmaceutical Manufacturing Site

  Increased availability of IV solutions to address shortages stemming from ongoing COVID-19 crisis

  Read More
• Wednesday, December 8, 2021

  B. Braun Announces Nationwide Availability of Magnesium Sulfate Family of Products

  Ready-to-Use Drugs are Manufactured in the USA to Help Ensure the Reliable Supply for Healthcare Providers

  Read More
• Thursday, December 2, 2021

  B. Braun Medical Launches Next Generation OnGuard® 2 CSTD

  Designed to provide simple, safe, and easy-to-use protection for healthcare workers

  Read More
• Tuesday, September 21, 2021

  B. Braun Launches CARESAFE™ IV Administration Sets With Optional AirStop

  First Robust Portfolio of IV Sets Not Made With PVC and DEHP

  Read More
• Thursday, April 29, 2021

  No Patient Asks to Be Stuck More than Once — B. Braun Unveils New Data-Driven Program Designed to Improve Patients’ Experience with Intravenous Therapies

  New Peripheral Advantage® Program Delivers Skills and Assets That Empower Nurses to Improve Patient Outcomes with First-Stick Success

  Read More
• Tuesday, February 2, 2021

  B. Braun Infusomat® Space® Infusion Pump Receives 2021 Best in KLAS Award for Traditional Smart Pumps

  Read More
• Thursday, August 27, 2020

  B. Braun Receives FDA Clearance for SpaceStation MRI: Allows Space® Infusion Pumps to Continuously Deliver Medications Within the MRI Suite

  Read More
• Tuesday, August 25, 2020

  Philips and B. Braun receive FDA clearance for breakthrough Onvision® Needle Tip Tracking technology for regional anesthesia

  Read More
• Sunday, April 19, 2020

  B. Braun Medical Inc. Issues Voluntary Nationwide Recall of one (1) lot of Ceftazidime for Injection USP and Dextrose Injection USP (50 mL), Duplex Container Due to Out-of-Specification Results for High Molecular Weight Polymers

  Read More